Loomis Pharma joins the UK Cannabis Trades Association

Loomis Pharma is pleased to announce that we are now an official member of the Cannabis Trades Association (CTA) in the UK.

Our membership underscores our commitment to safe, compliant and ethical logistics for prescribed medical cannabis in the United Kingdom. Unlike general CBD products, prescribed medical cannabis refers to regulated, prescription-only treatments which may contain CBD, THC, or both. Our role is to ensure these products are transported securely and in line with the highest regulatory and industry standards.

Why this matters

The UK medical cannabis sector is evolving quickly. By joining the CTA, Loomis Pharma is taking an active role in supporting best practice and responsible growth. Membership allows us to:

• Stay ahead of regulation – benefiting from regular updates and sector insights so our services remain aligned with healthcare and compliance requirements.
• Engage with peers and experts – contributing to industry discussions, events and working groups that shape the future of prescribed medical cannabis in the UK.
• Reinforce trust and quality – ensuring that every journey we manage supports transparency, patient safety and high standards across the supply chain.

Looking forward

Through the CTA, we look forward to collaborating with fellow members, regulators, and stakeholders to strengthen the framework for prescribed medical cannabis logistics. Our focus remains clear: delivering trusted, secure solutions that serve patients and support the growth of a compliant and responsible sector in the UK.